Identification of novel antigens that protect against systemic meningococcal infection (Q46554450)

23 December 2017

title

Identification of novel antigens that protect against systemic meningococcal infection (English)

1 reference

23 December 2017

author name string

Yaohui Sun

1

1 reference

23 December 2017

Yanwen Li

2

1 reference

23 December 2017

Rachel M Exley

3

1 reference

23 December 2017

Megan Winterbotham

4

1 reference

23 December 2017

Catherine Ison

5

1 reference

23 December 2017

Harry Smith

6

1 reference

23 December 2017

Christoph M Tang

7

1 reference

23 December 2017

language of work or name

English

0 references

publication date

14 April 2005

1 reference

23 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

32

1 reference

23 December 2017

page(s)

4136-4141

1 reference

23 December 2017

ABC of meningococcal diversity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Update on meningococcal disease with emphasis on pathogenesis and clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Development of vaccines against meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Highly ConservedNeisseria meningitidisInner‐Core Lipopolysaccharide Epitope Confers Protection against Experimental Meningococcal Bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Functional genomics of Neisseria meningitidis pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

In vivo genetic analysis of bacterial virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Cloning and functional characterization of Neisseria gonorrhoeae tonB, exbB and exbD genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Neisseria meningitidis tonB, exbB, and exbD genes: Ton-dependent utilization of protein-bound iron in Neisseriae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Human immunity to the meningococcus. I. The role of humoral antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Neisseria lactamica protects against experimental meningococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Multiple mechanisms of phase variation of PorA in Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.03.015

1 reference

23 December 2017

PubMed ID

15964482

1 reference

23 December 2017